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Abstract Prostacyclin and thromboxane A2 produced from 
prostaglandin H2 are known to be important modulators with 
opposite biological activities. To examine possible roles of these 
prostanoids in immune responses, we have studied the gene 
expression of prostacyclin synthase (PGIS) and thromboxane 
synthase (TXS) in murine resident macrophages or in macro-
phages elicited with casein or bacillus Calmette-Guérin (BCG). 
Northern blot analyses showed that the PGIS mRNA was 
expressed in a decreasing order in the resident, and casein- and 
BCG-elicited macrophages. In contrast, the TXS mRNA was 
expressed in an increasing order in the resident, and casein- and 
BCG-elicited macrophages. On the other hand, the mRNA for 
cyclooxygenase-2, which produces PGH2 and participates in the 
production of prostanoids in inflammation, was expressed in both 
the resident and BCG-elicited macrophages but barely in the 
casein-elicited cells. In situ hybridization analysis showed that 
the expression of mRNAs for PGIS and TXS was ascribable not 
only to the alteration of the expression levels of both mRNAs in 
the each macrophage but also to the changes in subpopulations of 
the cells expressing these mRNAs. These observations suggested 
that the inverse gene expression of PGIS and TXS in 
macrophages contributes to immune responses by modulating 
the relative levels of prostacyclin and thromboxane A2. 
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1. Introduction 
Prostacyclin (prostaglandin I2: PGI2) and thromboxane 
(TX) A2 are produced from the same substrate PGH2 by their 
specific synthases, prostacyclin synthase (PGIS) and throm-
boxane synthase (TXS), respectively. Since PGI2 and TXA2 
are opposing modulators in the vascular construction and 
platelet aggregation, the balance between production of 
PGI2 by vessel walls and the production of TXA2 by platelets 
is postulated to be important in the maintenance of vascular 
integrity [1]. PGI2 and TXA2 have been also considered to be 
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important modulators in the immune system. PGI2 has been 
suggested to be an inhibitor of macrophage activation and its 
analog OP-41483 is reported to be effective at suppressing the 
lymphokine-stimulated la antigen expression [2]. On the other 
hand, a TXA2 agonist is reported to induce apoptosis of im-
mature thymocytes highly expressing TXA2 receptor [3]. 
However, the physiological significance of the balance be-
tween the production of PGI2 and TXA2 in the immune sys-
tem still remains to be elucidated. 
We and other investigators have isolated the cDNAs encod-
ing human, porcine, rat and murine TXS [4-7], and bovine, 
human and rat PGIS [8-12]. Interestingly, rat TXS and PGIS 
cDNAs have been isolated from the identical cDNA library 
derived from peritoneal macrophages [11], indicating a possi-
ble coexistence of the both enzymes in the same preparation 
of the cells. It has been reported that the production of PGs 
including PGI2 in elicited macrophages was less than that in 
resident macrophages, whereas the production of TXA2 was 
selectively conserved when stimulated with agonists such as 
zymosan and arachidonic acid [13,14]. Furthermore, the pro-
file of prostanoids produced by macrophages elicited with an 
acute bacterial infection of bacillus Calmette-Guérin (BCG) or 
Listeria monocytogenes was different from that by resident 
peritoneal macrophages or macrophages elicited with non-
bacterial inflammatory reagents such as casein [15]. Recent 
studies have also shown that the inducible isoform of cyclo-
oxygenase (COX), COX-2 predominantly regulates the pro-
duction of PGs and TXA2 in activated macrophages [16,17]. 
Therefore, the balance of the production of PGI2 and TXA2 
appears to be important in macrophages as cellular regulators 
of immune responses. However, there has been no report de-
scribing the balance of the expression of TXS and PGIS in 
macrophages. 
Here, we have studied the murine gene expression of PGIS 
and TXS as well as COX-2 in resident macrophages or in 
macrophages elicited with casein or bacillus Calmette-Guérin 
(BCG) in vivo, indicating a possibility that the inverse gene 
expression of PGIS and TXS contribute to immune responses 
by modulating the relative levels of PGI2 and TXA2. 
2. Materials and methods 
2.1. Molecular cloning and characterization of mouse PGIS and TXS 
cDNAs 
Murine PGIS cDNA clone (λΜΡΟΙ85) was obtained from a mouse 
macrophage cDNA (λ-gt 11) library (Clontech) by a plaque hybridiza-
tion method using the bovine PGIS cDNA [8] radiolabeled with 
[a-32P]dCTP (Amersham) by the random-priming method [18]. Hy-
bridization was carried out overnight at 60°C and the membranes 
were washed at 60°C for 1 h in 3 X SSC (0.45 M NaCl and 45 mM 
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sodium citrate, pH 7.0) containing 0.1% SDS. The positive clone 
XMPGIS5 was isolated and the cDNA insert excised by EcoRI diges-
tion was ligated into pBluescript II SK(—) for sequence analysis. A 
murine TXS cDNA clone was obtained by polymerase chain reaction 
(PCR) using DNA from the macrophage cDNA library as a template. 
Primers, 5'-AATGGAAGTGTTGGGGCTTC-3', nucleotide residues 
- 1 to 19 and 5'-AACTCTCCATCTCCACACGA-3', complementary 
to nucleotide residues 1671 to 1692, were synthesized according to the 
nucleotide sequence of murine TXS cDNA according to [7]. The con-
ditions of PCR amplification were as follows: denaturation at 94°C 
for 1 min, annealing at 53°C for 2 min and extension at 72°C for 4 min 
for a total of 30 cycles after incubation at 95°C for 5 min. The 
recombinant plasmid pMTXl was obtained by ligation with the 
PCR product into pCR™II by the aid of TA cloning kit (Stratagene) 
for further analysis. The nucleotide sequence analysis was performed 
on a model 373A DNA sequencer (Applied Biosystems) and some 
sequences were further confirmed using [a-32P]dCTP and BcaBEST 
dideoxy sequencing kit (Takara Shuzo, Kyoto). Computer analysis 
was performed with the aid of the GENETYX-MAC program sup-
plied by Software Development (Tokyo). 
2.2. Preparation of murine peritoneal macrophages 
Male C57BL/6 mice at 8-12 weeks of age were purchased from 
Japan SLC (Shizuoka). Peritoneal macrophages were harvested from 
34 mice with no treatment as resident macrophages, 21 mice stimu-
lated with casein and 17 mice stimulated with BCG. For in vivo 
stimulation, mice were injected intraperitoneally with 1 ml of phos-
phate-buffered saline (PBS) containing 5% casein or 1 mg dry weight 
of BCG before 4 days of the harvest. Peritoneal macrophages were 
obtained by lavaging of the peritoneal cavity with 5 ml of PBS on ice. 
Harvested peritoneal cells were centrifuged at 400 Xg for 10 min at 
4°C, resuspended in Dulbecco's modified Eagle medium (Life Tech-
nologies) containing 10% heat-inactivated fetal calf serum and 4X106 
cells were seeded in each 90-mm tissue culture dish. After incubation 
for 2 h at 37°C in a humidified atmosphere of 5% CO2 in air, the 
nonadherent cells were removed by washing with PBS 3 times. Using 
this method, 4.6 X107, 5.8 X107 and 9.0X 107 cells were obtained for 
RNA preparations from mice with no treatment and mice elicited 
with casein and BCG, respectively. Over 90% of the adherent cells 
prepared were identified as macrophages by Wright's staining. 
2.3. Northern blot analysis 
Total RNA was isolated from the adherent macrophages according 
to the acid guanidium thiocyanate procedure [19]. Twenty micrograms 
of total RNA was electrophoresed on a 1.0% agarose gel containing 
1.5% formaldehyde, and transferred to a nylon membrane. The mem-
brane was hybridized overnight with 32P-labeled cDNA for murine 
PGIS (nucleotide - 3 5 to 1127) and was washed at 65°C for 1 h in 
O.lxSSC containing 0.1% SDS. The same membrane was also hy-
bridized with labeled cDNAs amplified by PCR for mouse TXS (nu-
cleotides 102 to 1221) [7], rat COX-1 (nucleotides 299 to 1733) [20], 
COX-2 (nucleotides 202 to 1685) [21], murine a chain of la antigen 
and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (nu-
cleotides 83 to 1130), respectively. The cDNA probe for the murine 
a chain of la antigen was prepared by the reverse transcription-PCR 
method with total RNA from the murine BCG-elicited macrophages 
as described [22]. 
2.4. In situ hybridization 
The adherent macrophages described as above were removed from 
the plates by gently scraping after the incubation of PBS supple-
mented with 10 mM EDTA in 10 min. The collected macrophages 
were cytospun onto glass microscope slides. The ücoRI-digested frag-
ment (nucleotides —35 to 1127) of murine PGIS cDNA from 
XMPGIS5 or the fragment (nucleotides 102 to 1221) of murine TXS 
cDNA from pMTXSl were subcloned into the .EcoRI site of pBlue-
script, respectively. In situ hybridization was carried out according to 
the method described previously [10]. Each antisense RNA was syn-
thesized in vitro by T7 RNA polymerase in the presence of [35S]CTP 
(NEN, 37 TBq/mmol). The resulting RNAs were hydrolyzed in 0.1 M 
sodium bicarbonate buffer (pH 10.6) to give fragments with sizes of 
approximately 150 nucleotides. Cell preparations were fixed with 4% 
paraformaldehyde, treated with 0.25% acetic anhydride, dehydrated in 
ethanol, and incubated with the 35S-labeled antisense RNA probe for 
PGIS or TXS in the hybridization solution (50% formamide, 2XSSC, 
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10 mM Tris-HCl (pH 8.0), 1X Denhardt's, 10% dextran sulfate, 
0.2% SDS, salmon sperm DNA (500 μg/ml), tRNA (250 \ipm\) and 
100 mM dithiothreitol) at 42°C for 16 h. The preparations were 
washed with 2XSSC containing 10 mM 2-mercaptoethanol at 60°C 
for 1 h, treated with RNase-A (20 μg/ml) at 37°C for 30 min and then 
washed with 0.1 XSSC containing 10 mM 2-mercaptoethanol at 60°C 
for 1 h. After dehydration in ethanol, the cell preparations were 
dipped into emulsion NTB-2 (Kodak) diluted with an equal volume 
of distilled water, developed with Freshline-L (Chugai Photo, Tokyo) 
after 3 weeks of exposure, and counterstained with hematoxylin-eosin. 
Inasmuch as the limits of cytoplasms were slightly defined with our 
stain, we counted the grains over the cell or those that were around 
the nucleus. A minimum of 100 cells was counted. The in situ hybrid-
ization of macrophages in this study was repeated 3 times with the 
separately prepared cells. 
3. Results and discussion 
3.1. Cloning and sequencing of murine PGIS and TXS cDNAs 
Screening a murine macrophage c D N A library with a bo-
vine PGIS c D N A as a probe [8] yielded a PGIS c D N A clone 
λ Μ Ρ ΰ Ι 8 5 with a 1665-bp insert. The nucleotide sequence 
analysis showed that λ Μ Ρ ϋ Κ δ contained the 35-bp 5'-un-
translated region, the 1503-bp open reading frame encoding 
a 501-amino-acid protein which has a calculated molecular 
mass of 57046 Da, and the 127 bp of the 3'-untranslated 
region (data not shown). The predicted amino acid sequence 
of the murine PGIS exhibited 84.6%, 85.8% and 94.6% sim-
ilarities with those of the bovine [8,9], human [10] and rat [11] 
enzymes, respectively. On the other hand, murine TXS c D N A 
(1713 bp) was obtained by P C R method using the primers 
prepared according to Zang et al. [7] and D N A from the 
murine macrophage c D N A library as a template. The nucleo-
tide sequence of the c D N A was agreed with the sequence in 
[7] except four nucleotide differences, one nucleotide insertion 
and one nucleotide deletion in the nucleotide sequence from 
229 to 262 (corresponding to the amino acid residues 77-87). 
The predicted amino acid sequence of the residues 77-87 from 
our sequence was almost identical to those of human [4], 
porcine [5] and rat [6] TXS, but was different from that of 
murine TXS [7]. 
3.2. Expression of PGIS and TXS mRNAs in murine peritoneal 
macrophages 
To evaluate the gene expression levels of PGIS and TXS in 
macrophages, total R N A s have been isolated from resident 
macrophages or macrophages elicited with casein or BCG. 
Expression of the m R N A for a chain of l a antigen in BCG-
elicited macrophages was higher than that in resident or ca-
sein-elicited macrophages (Fig. IB, lanes 1-3). This result 
agrees with the previous finding that la antigen is induced 
during activation of macrophages [23]. The murine m R N A 
for COX-1 , a house-keeping isozyme of COX, was constitu-
tively expressed (Fig. 1A, lanes 10-12) and the intensity of 
ethidium bromide-stained r R N A was also not changed in 
each macrophages (Fig. IB, lanes 7-9), al though the expres-
sion of G A P D H m R N A , which was usually used as an inter-
nal control of R N A loaded, was altered by activation of mac-
rophages (Fig. IB, lanes 4-6) . F r o m these results, expression 
of COX-1 not G A P D H m R N A was regarded as the internal 
control in this study. 
The murine PGIS m R N A as a single species of 1.9 kb was 
expressed in a decreasing order in the resident, and casein-
and BCG-elicited macrophages (Fig. 1A, lanes 1-3). In con-
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Fig. 1. Expressions of PGIS, TXS, COX-1 and COX-2 (A) or a chain of la antigen and GAPDH (B) mRNAs in murine peritoneal macro-
phages. Total RNA was isolated from resident (lanes 1, 4, 7 and 10), casein-induced (lanes 2, 5, 8 and 11) and BCG-elicited (lanes 3, 6, 9 and 
12) macrophages, and 20 μg was fractionated through formaldehyde-containing agarose gels. The fractionated RNAs were transferred to a ny-
lon membrane and hybridized with a 32P-labeled murine PGIS probe. After analysis of the hybridization signals, the blot was stripped in boil-
ing 0.1% SDS and rehybridized with a 32P-labeled murine TXS probe and then, with a 32P-labeled COX-2, COX-1, a chain of la antigen and 
GAPDH probes after stripping, successively. The positions of 28S and 18S ribosomal RNAs with ethidium bromide-staining patterns on the 
nylon membrane (B, lanes 7-9), are indicated on each right. 
trast, the single species of murine TXS mRNA with a size of 
2.1 kb was expressed in an increasing order in the resident, 
and casein- and BCG-elicited macrophages (Fig. 1A, lanes 4 -
6). On the other hand, mRNA for COX-2, which possibly 
participates in the production of prostanoids in inflammation, 
was expressed in both the resident and BCG-elicited but 
barely in casein-elicited macrophages (Fig. 1A, lanes 7-9). 
From these results, not only COX-2 but also PGIS and 
TXS, which are terminal enzymes in synthesis of bioactive 
prostanoids, are regulated during immune responses in macro-
phages. Concerning the COX-2 expression, our data may also 
provide a novel insight on regulation of COX-2 gene expres-
sion, that is, not only in BCG-elicited macrophages under an 
inflammatory condition but also in resident macrophages 
under a physiological condition. 
3.3. In situ hybridization analysis of PGIS and TXS mRNAs 
A population of resident or activated macrophages is sug-
gested to exist as a mixture of several phenotypes which ex-
hibit different patterns of eicosanoid synthesis [14]. Thus, the 
altered expression of PGIS and TXS by activation in macro-
phages may reflect the change of the subpopulations of mac-
rophages expressing these enzymes. To examine the possibil-
ity, the expression levels of PGIS and TXS mRNAs in each 
cell (Fig. 2) was measured by in situ hybridization analysis. 
According to the hybridization signals, the macrophages were 
roughly classified into two types of cells with and without 
expression of PGIS mRNA (Fig. 2A-C) or TXS mRNA 
(Fig. 2D-F), respectively. To estimate the population of cells 
expressing PGIS or TXS mRNA, the grains over a cell were 
counted for a minimum of 100 cells in each macrophage prep-
aration. As a control experiment, over 99% of total cells gave 
less than nine grains corresponding to PGIS or TXS mRNA 
in the presence of a 100-fold excess of each unlabeled probe. 
Therefore, cells with more than 10 grains were defined as cells 
expressing PGIS or TXS mRNA in this study. As shown in 
Fig. 3, 37%, 24% or 10% of cells expressing PGIS mRNA and 
16%, 25% or 58% of cells expressing TXS mRNA were ob-
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Fig. 2. In situ hybridization of murine peritoneal macrophages with a cRNA probe for PGIS or TXS. Macrophages (105 cells) were cytospun 
and fixed onto glass slides. After prehybridization, a 35S-labeled cRNA for PGIS or TXS was allowed to hybridize to permeabilized cells over-
night. Hybridized cRNAs were detected by overlaying photographic emulsion over the slides and were visualized by the development of grains 
within the emulsion, then counterstained with hematoxylin-eosin. Representative 400 X amplified fields for resident (A,D), and casein- (B,E) 
and BCG-elicited (C,F) macrophages hybridized with a 35S-labeled cRNA probe for PGIS (A-C) or TXS (D-F) are shown. 
served in resident, casein- or BCG-treated macrophages, re-
spectively. The decrease in the macrophage subpopulations 
expressing PGIS mRNA was accompanied by the increase 
in the subpopulations expressing TXS mRNA. This finding 
is, to some extent, explainable by monocyte migration during 
immune responses as previously reported [24]. In our experi-
ments, however, about 1.4X106, 2.8X106 and 5.3X106 cells/ 
mouse were obtained as resident, and casein- and BCG-eli-
cited macrophages, respectively. Hence, only a 3.8-fold in-
crease of the cell number by monocyte migration can not 
! 
o 
¡ 
1 
i 
100 
resident casein BCG 
Fig. 3. Population of cells expressing PGIS or TXS mRNA in mu-
rine peritoneal macrophages. According to the results of in situ hy-
bridization as shown in Fig. 2, the grains over the cell expressing 
PGIS or TXS mRNA were counted for a minimum of 100 cells. 
Percentages of cells with over 10 grains of resident, and casein- and 
BCG-elicited macrophages were indicated. Average grain numbers 
of PGIS mRNA in cells giving over 10 grains were 16±5, 17±6 
and 15 ±5 in resident, and casein- and BCG-elicited macrophages, 
respectively. Average grain numbers of TXS mRNA in cells yielding 
over 10 grains were 14 ±5, 17 ±6 and 20 ±7 in resident, and casein-
and BCG-elicited macrophages, respectively. 
totally explain the significantly different levels of PGIS and 
TXS mRNAs between resident and BCG-elicited macro-
phages as shown in Fig. 1. From these results, the inverse 
expression of mRNAs for PGIS and TXS in resident and 
activated macrophages were ascribable not only to the alter-
ation of the expression levels of both mRNAs in each cell but 
also to the changes in subpopulations of the cells expressing 
different levels of these mRNAs. 
In this communication, we have shown that the expression 
of PGIS and TXS mRNAs is inversely regulated during acti-
vation in macrophages. It is clear that there exist a population 
of macrophages expressing neither PGIS nor TXS mRNA 
because the sums of percentages of cells expressing PGIS 
and TXS mRNAs are 53, 49 and 68% in resident, and casein-
and BCG-treated macrophages, respectively (Fig. 3). At 
present, however, we were unable to show the presence of a 
population of cells expressing both PGIS and TXS mRNAs 
since we have not been successful in differential display of 
PGIS and TXS mRNAs on a cell. Remarkably, the expression 
pattern of TXS mRNA was similar to that of mRNA for a 
chain of la antigen known as an activation marker of macro-
phages (Fig. 2). On the other hand, COX-2 mRNA was barely 
expressed in casein-treated macrophages which are reported to 
be in an intermediate stage of the activation (Fig. 1) [25]. 
These results suggest a possibility that macrophages are clas-
sified in terms of the expression of PGIS, TXS and COX-2 as 
activation markers of the macrophage. 
Acknowledgements: We thank Dr. Ryotaro Yoshida (Osaka Bio-
science Institute), Drs. Chieko Yokoyama, Shuntaro Hara, Toshihisa 
Hatae and Tomoko Yabuki (National Cardiovascular Center) for 
helpful discussions and also Tamiko Sugimoto, Setsuko Bandoh and 
Fumie Kishigami for technical assistance. This work was supported in 
part by grants from the Ministry of Health, and Welfare and the 
Ministry of Education, Science, Culture and Sports of Japan and 
also by Special Coordination Funds for Promoting Science and Tech-
nology from the Science and Technology Agency of Japan. 
246 S. Kuwamoto et al.lFEBS Letters 409 (1997) 242-246 
References 
[1] S. Moneada, J.R. Vane, N. Engl. J. Med. 300 (1979) 1142-1147. 
[2] C.S. Tripp, A. Wyche, E.R. Unanue, P. Needleman, J. Immnol. 
137 (1986) 3915-3920. 
[3] F. Ushikubi, Y. Aiba, K. Nakamura, T. Namba, M. Hirata, O. 
Mazda, Y. Katsura, S. Narumiya, J. Exp. Med. 178 (1993) 1825-
1830. 
[4] C. Yokoyama, A. Miyata, H. Ihara, V. Ullrich, T. Tanabe, Bio-
chem. Biophys. Res. Commun. 178 (1991) 1479-1484. 
[5] R.-F. Shen, L. Zhang, S.J. Baek, H.-H. Tai, K.-D. Lee, Gene 140 
(1994) 261-265. 
[6] Y. Tone, A. Miyata, S. Hara, S. Yukawa, T. Tanabe, FEBS Lett. 
340 (1994) 241-244. 
[7] L. Zhang, M.B. Chase, R.-F. Shen, Biochem. Biophys. Res. 
Commun. 194 (1993) 741-748. 
[8] S. Hara, A. Miyata, C. Yokoyama, H. Inoue, R. Brugger, F. 
Lottspeich, V. Ullrich, T. Tanabe, J. Biol. Chem. 269 (1994) 
19897-19903. 
[9] B. Pereira, K.K. Wu, L. Wang, Biochem. Biophys. Res. Com-
mun. 203 (1994) 59-66. 
[10] A. Miyata, S. Hara, C. Yokoyama, H. Inoue, V. Ullrich, T. 
Tanabe, Biochem. Biophys. Res. Commun. 200 (1994) 1728-
1734. 
[11] Y. Tone, H. Inoue, S. Hara, C. Yokoyama, T. Hatae, H. Oída, S. 
Narumiya, R. Shigemoto, S. Yukawa, T. Tanabe, Eur. J. Cell 
Biol. 72 (1997) 268-277. 
[12] T. Tanabe, V. Ullrich, J. Lipid Mediators Cell Signal. 12 (1995) 
243-256. 
[13] W.A. Scott, N.A. Pawlowski, M. Andreach, Z.A. Cohn, J. Exp. 
Med. 155 (1982) 535-547. 
[14] C.S. Tripp, K.M. Leahy, P. Needleman, J. Clin. Invest. 76 (1985) 
898-901. 
[15] S.E. Wenzel, J.B. Trudeau, D.W.H. Riches, J.Y. Westcott, P.M. 
Henson, Inflammation 7 (1993) 743-756. 
[16] S.T. Reddy, H.R. Herschman, J. Biol. Chem. 269 (1994) 15473-
15480. 
[17] T. Nanayama, S. Hara, H. Inoue, C. Yokoyama, T. Tanabe, 
Prostaglandins 49 (1995) 371-1995. 
[18] A.P. Feinberg, B. Vogelstein, Anal. Biochem. 132 (1983) 6-13. 
[19] P. Chomczynski, N. Sacchi, Anal. Biochem. 162 (1987) 156-159. 
[20] L. Feng, W. Sun, Y. Xia, W.W. Tang, P. Chanmugam, E. Soyoo-
la, C.B. Wilson, D. Hwang, Arch. Biochem. Biophys. 307 (1993) 
361-368. 
[21] J. Sirois, L.O. Levy, D.L. Simmons, J.S. Richards, J. Biol. Chem. 
268 (1993) 12199-12206. 
[22] K. Hayakawa, D. Tarlinton, R.R. Hardy, J. Immunol. 152 (1994) 
4801^1807. 
[23] D.I. Beller, J.M. Kiely, E.R. Unanue, J. Immunol. 124 (1980) 
1426-1432. 
[24] C.S. Tripp, E.R. Unanue, P. Neeedleman, Proc. Nati. Acad. Sei. 
USA 83 (1986) 9655-9659. 
[25] T.A. Hamilton, J.E. Weiel, D.O. Adams, J. Immunol. 132 (1984) 
2285-2290. 
